The current clinical approach to newly diagnosed uterine cancer-Reference-Cited by-同舟云学术

The current clinical approach to newly diagnosed uterine cancer

Published:2020-06-22 Issue:7 Volume:20 Page:581-590
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Filippova Olga T.¹,Leitao Mario M.¹

Affiliation:

1. Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Funder

U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2020.1782750

Reference60 articles.

1. Cancer statistics, 2020

2. Howlander N, Noone AM, Krapcho M et al. SEER cancer statistics review, 1975–2013. 2016. [cited 2020 Feb 1]. Available from: https://seer.cancer.gov/archive/csr/1975_2013/

3. Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis

4. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

5. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of artificial intelligence techniques for gynaecological cancer: symptoms identification, prognosis and prediction;Artificial Intelligence Review;2024-07-29

2. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients;European Journal of Surgical Oncology;2024-01

3. Surgically Treated Brain Metastases from Uterine Origin: A Case Series and Systematic Review;World Neurosurgery;2023-05

4. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020;International Journal of Gynecologic Cancer;2021-11-02

5. C-reactive protein as a diagnostic and prognostic factor of endometrial cancer;Critical Reviews in Oncology/Hematology;2021-08